Wen-Jie Shu (Wenjie Shu)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 3

Top Topics

Reactive Oxygen Species

Top Venues

Molecular pharmaceutics

This page only lists publications with an associated author ORCID identifier.

Publications

Zhe Ma, Xiaojie Tian, Shijiang Yu, Wen-Jie Shu, Chuanxian Zhang, Lu Zhang, Fu Wang
Liver Fibrosis Amelioration by Macrophage-Biomimetic Polydopamine Nanoparticles via Synergistically Alleviating Inflammation and Scavenging ROS. Molecular pharmaceutics (2024)
Zhe Ma, Xiaojie Tian, Shijiang Yu, Wen-Jie Shu, Chuanxian Zhang, Lu Zhang, Fu Wang
Liver Fibrosis Amelioration by Macrophage-Biomimetic Polydopamine Nanoparticles via Synergistically Alleviating Inflammation and Scavenging ROS. Molecular pharmaceutics 21 (6) (2024)
Meng-Jie Zhao, Xiao Yao, Ping Wei, Chen Zhao, Meng Cheng, Dong Zhang, Wen Xue, Wen-Tian He, Weili Xue, Xinxin Zuo, Lei-Lei Jiang, Zhiyuan Luo, Jiaqi Song, Wen-Jie Shu, Han-Ye Yuan, Yi Liang, Hui Sun, Yan Zhou, Yu Zhou, Ling Zheng, Hong-Yu Hu, Jiwu Wang, Hai-Ning Du
O-GlcNAcylation of TDP-43 suppresses proteinopathies and promotes TDP-43's mRNA splicing activity. EMBO reports 22 (6) (2021)